Novavax (NVAX) Other Working Capital Changes (2010 - 2026)

Novavax's Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$51.0 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 91.56% year-over-year to -$51.0 million; the TTM figure through Mar 2026 stood at -$69.9 million (up 89.44% YoY), while the FY2025 annual figure was -$622.9 million, down 75.93% from the prior year.
• Other Working Capital Changes was -$51.0 million for Q1 2026 at Novavax, up from -$510.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $495.9 million in Q3 2025 to a low of -$604.0 million in Q1 2025.
• Historically, Other Working Capital Changes has averaged -$54.5 million across 5 years, with a median of -$51.5 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes jumped 506.53% in 2023, then plunged 55755.31% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$77.8 million in 2022, then surged by 506.53% to $316.4 million in 2023, then plunged by 100.29% to -$913000.0 in 2024, then slumped by 55755.31% to -$510.0 million in 2025, then soared by 90.01% to -$51.0 million in 2026.
• The last three Other Working Capital Changes figures came in at -$51.0 million (Q1 2026), -$510.0 million (Q4 2025), and $495.9 million (Q3 2025), per Business Quant data.